Forge Nano (NANO) News
NASDAQ: NANOTechnologyIndustrial Machinery/ComponentsUSD
3.04-0.08 (-2.56%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NANO news summary
We found 9 recent headlines mentioning Forge Nano (NANO): 1 in the past week and 9 in the past 30 days, most often from GlobeNewswire, Business Wire. For price context, NANO is down 2.56% at $3.04. The most recent story, "Forge Nano Reports Third Quarter 2026 Results; Raises Over $130 Million; Reiterates Guidance", was published by GlobeNewswire on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Forge Nano headlines
- Forge Nano Reports Third Quarter 2026 Results; Raises Over $130 Million; Reiterates GuidanceDENVER, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Forge Nano Holdings, Inc. (NASDAQ: NANO) (“Forge Nano” or the “Company”), a U.S.-based semiconductor equipment and advanced materials company pioneering…GlobeNewswire
- Nano One Reports Q3 2026 Results and Highlights Candiac Capacity Expansion ProgressVANCOUVER, British Columbia--(BUSINESS WIRE)---- $NANO--Nano One® Materials Corp. ("Nano One" or the "Company") has filed its condensed interim consolidated financial statements (the "financial…Business Wire
- Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital socialConformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés FinanciersGlobeNewswireNANO, NBTX
- Voting Rights and Shares Capital of the CompanyIn accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)GlobeNewswireNANO, NBTX
- Nanobiotix to Participate in Investor Conferences in NovemberPARIS and CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic…GlobeNewswireNANO, NBTX
- NANOBIOTIX PARTICIPERA À PLUSIEURS CONFÉRENCES INVESTISSEURS EN NOVEMBREPARIS et CAMBRIDGE, Mass., 09 nov. 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique…GlobeNewswireNANO, NBTX
- Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense MarketsCombination pairs Forge Nano’s Atomic Armor atomic layer deposition (ALD) platform with HZO’s high-volume Parylene and thin-film protective coating business and its blue-chip customer base in…GlobeNewswire
- NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de deuxième ligne ou plusDonnées présentées lors du Congrès 2026 de la Société européenne d’Oncologie Médicale (ESMO)GlobeNewswireNANO, NBTX
- NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous MelanomaData presented at the 2026 Congress of the European Society for Medical OncologyGlobeNewswireNANO, NBTX